Harrison Ball

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Mark F. Brady, Harrison Ball, Jonathan S. Berek · American Journal of Obstetrics and Gynecology · 1994 · 670 citations

Medicine, Gynecology, Surgery +16

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

J.T. Thigpen, John A. Blessing, Harrison Ball et al. · Journal of Clinical Oncology · 1994 · 389 citations

Medicine, Oncology, Pharmacology +17

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Stephen Williams, J A Blessing, S Y Liao et al. · Journal of Clinical Oncology · 1994 · 345 citations

Medicine, Oncology, Surgery +17

A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study

Harrison Ball, John A. Blessing, Samuel S. Lentz et al. · Gynecologic Oncology · 1996 · 235 citations

Medicine, Gynecology, Oncology +14

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · Journal of Clinical Oncology · 1995 · 221 citations

Medicine, Oncology, Surgery +16